Week in Review: February 10–14

First Ancient North American genome; cannabinoids connect hunger with olfaction and eating; biotechs explore crowdfunding; confronting creationism

Written byTracy Vence
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

MIKE WATERSInvestigators from the University of Copenhagen and their colleagues have sequenced the first ancient North American genome—that of the 12,600-year-old remains of an infant found buried in Montana. Comparative analyses suggested that the child descended from ancient Asians, not from Western Europeans. The work was published in Nature this week (February 12).

“This study, like other recent studies of ancient genomes, shows that genetic patterns have changed over time, and we must be cautious about inferring ancient patterns of human genetic variation from present-day patterns,” said molecular anthropologist Deborah Bolnick from the University of Texas at Austin, who was not involved in the work.

WIKIMEDIA, ALLEN INSTITUTE FOR BRAIN SCIENCECannabinoid type-1 (CB1) receptors in the olfactory bulb help increase olfaction, promoting feeding behavior in fasted mice, researchers from the French Institute of Health and Medical Research (INSERM) and elsewhere have found. Their work was published this week (February 9) in Nature Neuroscience.

“The study clearly establishes the relationship of food intake and olfactory processing and implicates the endocannabinoid system as a key player in this signaling pathway,” said Howard University College of Medicine’s Thomas Heinbockel, who was not involved in the work.

WIKIMEDIA, MPLAJAAs the US Securities and Exchange Commission (SEC) finalizes its rules for equity-based crowdfunding, American biotech firms are beginning to jump into the fray. QuantuMDx is one such firm that’s seeking crowd-based funds, to test its handheld device to diagnose malaria in the field. The company’s CEO told The Scientist that the Indiegogo campaign is as much about raising awareness as it is about raising money.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies